Pulse Biosciences (NASDAQ:PLSE) reported quarterly earnings results on February 19, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.26, missing the consensus estimate of $-0.25 by $0.01 per share. Revenue came in at $264.0K, beating the estimate of $250.0K.
Pulse Biosciences's stock moved following the earnings release. The stock currently trades at $23.47 with a market capitalization of $933.2M.